Results 71 to 80 of about 830,210 (192)

Quality and Readability of ChatGPT Performance on Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 11, Page 3026-3030, November 2026.
Abstract Background Chat Generative Pre‐trained Transformer (ChatGPT) is increasingly used for medical education and healthcare counseling. Objective To evaluate the reliability, quality, usefulness, and readability of ChatGPT‐4o responses to professional medical quizzes and patient frequently asked questions (FAQs) about Parkinson's disease (PD ...
Gabriele Riccio   +4 more
wiley   +1 more source

7 T MRI Connectivity‐Guided Reprogramming Improves Deep Brain Stimulation Motor Outcome in Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 11, Page 2834-2842, November 2026.
Abstract Background Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established treatment for Parkinson's disease (PD). Using 7‐Tesla (7 T) MRI connectivity analysis to visualize the patient‐specific STN motor subdivision, we hypothesize that reprogramming patients who are stimulated outside of this subdivision can improve their ...
Yarit Wiggerts   +6 more
wiley   +1 more source

Machine Learning Prediction of Hoehn and Yahr Scores at 5‐Years Post‐123I‐Ioflupane SPECT Imaging in a Real‐World Parkinson's Disease Dataset

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 11, Page 2843-2852, November 2026.
Abstract Background Parkinson's disease (PD) progression is highly heterogeneous, complicating clinical management and prognostication. While machine learning models have been developed using research datasets such as Parkinson's Precision Medicine Initiative (PPMI) and Parkinson's Disease Biomarkers Program (PDBP), their clinical translatability is ...
Xuehua Ye   +9 more
wiley   +1 more source

Modelling the Cost Effectiveness of Cholinesterase Inhibitors in the Management of Mild to Moderately Severe Alzheimer's Disease

open access: yes
Alzheimer's-disease, Cholinesterase-inhibitors, Cost ...
Andrew Yeates, Nick Bosanquet
core  

Antiseizure Medication Dispensing Before and After Initiation of Antidementia Medicines: A Population‐Based Matched Cohort Study

open access: yesPharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.
ABSTRACT Purpose Seizures and behavioural and psychiatric features may prompt antiseizure medication (ASM) use in dementia. We examined whether increased ASM dispensing precedes or follows initiation of antidementia treatment to inform hypotheses about when these indications emerge.
Osvaldo P. Almeida   +4 more
wiley   +1 more source

Ruta graveolens L. in Evidence‐Based Phytotherapy: Pharmacological Activities, Bioactive Compounds and Safety

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6320-6369, November 2026.
Graphical representation of ethnomedical uses, major bioactive compounds, pharmacological potential and toxicological risks of Ruta graveolens L. ABSTRACT Ruta graveolens L. is widely used in traditional European, Asian, African, and South American medicine for digestive, nervous, cardiovascular, respiratory, and reproductive disorders.
Tetiana Serhiienko   +3 more
wiley   +1 more source

Research Trends and Mechanistic Insights Into Natural Medicines for Alzheimer's Disease: A Bibliometric Analysis and Narrative Review

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6490-6515, November 2026.
Research landscape and mechanistic insights into natural medicines for Alzheimer's disease. ABSTRACT Natural medicines have been widely investigated for Alzheimer's disease (AD), but the development of this field and the relationship between bibliometric themes and experimental evidence remain insufficiently characterized.
Maoning Wang   +8 more
wiley   +1 more source

Ginsenoside Rh1 Attenuates Alzheimer's Disease‐Like Deficits by Modulating Oxidative Stress and Mitochondrial Dysfunction via SIRT1‐Related Signaling

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6767-6790, November 2026.
Rh1 attenuates oxidative stress and mitochondrial dysfunction through SIRT1‐related signaling. ABSTRACT Alzheimer's disease (AD) remains a progressive neurodegenerative disorder with limited therapeutic options. Ginsenoside Rh1 has been reported to possess neuroprotective properties, yet its specific role and underlying mechanisms in AD are not fully ...
Shi‐Lu Li   +10 more
wiley   +1 more source

Drug Persistency with Cholinesterase Inhibitors for Elderly Patients with Alzheimer`s Disease in Korea

open access: yes, 2009
Background: Persistence to Cholinesterase-Inhibitors (ChEIs) treatment in Alzheimers disease (AD) patients sustains cognitive, functional, and behavioral benefits and delays the progress of the disease.
Choi, Nam-Kyong   +5 more
core  

Vitamin D Supplementation and Mortality in the Elderly: A Review of a Meta‐Analysis of Randomized Controlled Trials Using the REB Method

open access: yesFundamental &Clinical Pharmacology, Volume 40, Issue 6, November 2026.
ABSTRACT Background The results of randomized controlled trials (RCTs) regarding the effect of vitamin D supplementation on mortality reduction are conflicting. Objective The aim of this study was to assess the level of evidence through a sensitivity analysis of the meta‐analysis by Shah et al.
Natalia Kostakis   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy